Symbol="HALO"
AssetType="Common Stock"
Name="Halozyme Therapeutics Inc"
Description="Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company is headquartered in San Diego, California."
CIK="1159036"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11388 SORRENTO VALLEY ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="5696477000"
EBITDA="400563000"
PERatio="32.53"
PEGRatio="-2.5"
BookValue="1.145"
DividendPerShare="0"
DividendYield="0"
EPS="1.33"
RevenuePerShareTTM="5.75"
ProfitMargin="0.302"
OperatingMarginTTM="0.424"
ReturnOnAssetsTTM="0.114"
ReturnOnEquityTTM="1.052"
RevenueTTM="773653000"
GrossProfitTTM="454205000"
DilutedEPSTTM="1.33"
QuarterlyEarningsGrowthYOY="2.5"
QuarterlyRevenueGrowthYOY="0.451"
AnalystTargetPrice="51.8"
TrailingPE="32.53"
ForwardPE="23.47"
PriceToSalesRatioTTM="13.28"
PriceToBookRatio="81.58"
EVToRevenue="15.76"
EVToEBITDA="31.48"
Beta="1.238"
num_52WeekHigh="59.46"
num_52WeekLow="29.85"
num_50DayMovingAverage="39.18"
num_200DayMovingAverage="43.64"
SharesOutstanding="131680000"
DividendDate="None"
ExDividendDate="None"
symbol="HALO"
open="43.24"
high="43.39"
low="42.35"
price="42.62"
volume="694788.00"
latest_trading_day="2023-08-21"
previous_close="43.26"
change="-0.64"
change_percent="-1.4794%"
aroon_positive_momentum_days="31"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="31"
Volume_recent_avg="1180820"
Change_recent_avg="0.04"
Delta_recent_avg="1.24"
Variance_recent_avg="0.62"
Change_ratio_recent_avg="0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="31"
Aroon_momentum_negative="69"
image_negative_thumbnail_id_1="1147"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0180.jpeg"
image_negative_thumbnail_id_2="1112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0145.jpeg"
image_neutral_thumbnail_id_1="575"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="688"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_positive_thumbnail_id_2="666"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0042.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
